A Bath-headquartered company which produces cannabis-derived products is planning to launch its own Apple-style retail offering as part of a raft of projects it hopes will grow it into one of the largest businesses in the sector.
George Botanicals, which operates from a family-owned farm in Somerset, produces Cannabinoid (CBD) products and has a hemp-growing license. It is backed by Sativa Investments.
As well as the retail offering, the company also has plans to open up a £12m glasshouse in the region to grow plants to produce the medicinal and psychoactive chemical THC, as well as its own CBD extraction setup.
Sativa Investments (NEX:SATI) is the UK’s first medicinal cannabis investment vehicle. After investing in two North American businesses, it is now progressing a UK seed to consumer investment strategy with 100% ownership of businesses involved in the production, testing and compliance, research & development including pharmacology, commercialisation and sales & marketing of medicinal cannabis and cannabidiol products. Two UK businesses, George Botanicals and PhytoVista Laboratories, are already fully operational.